A Community Bio-Tech Lab Offers a Crash Course in Designing Life — Open to the Public
By Adam Wernick,
PRI
| 06. 05. 2015
Untitled Document
“Scientists in general are awful at communicating their work to the general public,” says Jorgensen, the director of Genspace. “The consumer is already using genetically modified and genetically engineered products in their daily life. So, wouldn't it be nice if the end user were also someone who could have a say about what this technology was used for?“
Genspace, which opened in downtown Brooklyn in 2009, is the world's first community bio-lab. It offers a three-class crash course in synthetic biology to anyone who is interested. It also has a working lab space where the general public is invited to come in and learn how to do genetic science — hands on.
At Genspace, Wetherell experimented with her own DNA. Here her DNA is suspended in an agarose gel that is charged by an electical current that separates the proteins
Credit: Julia Wetherell
For $100 a month, Genspace members have access to the standardized gene sets that are the building blocks of synthetic biology. If that sounds daunting, consider this: Non-scientists make up a big part of...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
